Does longterm-hospitalisation influence the cardiovascular morbidity in schizophrenics?;Beeinflusst Dauerhospitalisierung die kardiovaskulare Morbiditat bei Schizophrenen?

Fortschritte der Neurologie Psychiatrie

Volumn 64, Issue 6, 1996, Pages 212-220

  Steinert, T ^a   Wolfersdorf, M ^a   Thoma, Hendrika ^a   Marpert, M ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; BLOOD; CAUSE OF DEATH; COMPARATIVE STUDY; GERMANY; LENGTH OF STAY; MIDDLE AGED; MORTALITY; RISK FACTOR; SMOKING; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHOLESTEROL; DEPRESSIVE DISORDER; FEMALE; GERMANY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SCHIZOPHRENIA; SMOKING;

EID: 0030156303     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996388     Document Type: Article

References (49)

1. Adamantidis, M. M., P. Kerram, B. Dupuis: In-vitro electrophysiological detection of iatrogenic arrhythmogenicity. Fundam. Clin. Pharmacol. 8 (1994) 391-407
2. Allgulander, C., P. Allebeck, T. R. Przybeck, J. P. Rice: Risk of suicide by psychiatric diagnosis in Stockholm county. A longitudinal study of 80 970 psychiatric inpatients. Eur. Arch. Psychiatry Clin. Neurosci. 241 (1992) 323-326
3. Alstrom, C. H.: Mortality in mental hospitals with especial regard to tuberculosis. Acta Psychiatr. Neurol. Scand. suppl. 24 (1942)
4. Anderson, C., J. Connelly, E. C. Johnstone, D. G. C. Owens: Cause of Death. Br. J. Psychiaty 159 (suppl. 13) (1991) 30-33, 43-46
5. Arzneimittelkommission der Deutschen Ärzteschaft: Zur kardiotoxischen Wirkung trizyklischer Psychopharmaka. Dt. Ärztebl. 44 (1971) 2925
6. Baldwin, J. A.: Schizophrenia and physical disease: A preliminary analysis of data from the Oxford Record Linkage Study. In: Hemmings, G. (ed.): The biochemistry of schizophrenia and addiction. Lancaster, MTP Press, 1980
7. Black, D. W.: Mortality in schizophrenia. The Iowa record-linkage-study: A comparison with general population in mortality. Psychosomatics 29 (1988) 55-66
8. Brown, R. P., J. H. Kocsis: Sudden death and antipsychotic drugs. Hosp. Comm. Psych. 35 (1984) 486-491
9. Brugha, T. S., J. K. Wing, B. L. Smith: Physical health of the long-term mentally ill in the community. Is there unmet meed? Br. J. Psychiatry 155 (1989) 777-781
10. Burke, A. W.: Morbidity and its prevalence in psychiatric patients. In: Koranyi, E. K. (ed.): Physical illness in the psychiatric patient. Carles C. Thomas Publisher, Springfield/Illinois 1987
11. Castellani, S., M. G. Ziegler, D. P. van Kammen, P. E. Alexander, S. G. Siris, C. R. Lake: Plasma norepinephrine and dopamine-b-hydroxylase activity in schizophrenia. Arch. Gen. Psychiatry 39 (1982) 1145-1149
12. Craig, T. J.: Medication use and death attributed to asphyxia among psychiatric patients. Am. J. Psychiatry 137 (1980) 1366-1373
13. Der Bundesminister für Gesundheit (Hrsg.): Daten des Gesundheitswesens. Ausgabe 1991. Nomos, Baden-Baden 1991
14. Dupont, A., O. Möller-Jensen, E. Stömgren, A. Jablensky: Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In: ten Horn, G. H. H. M., R. Giel, W. H. Gulbinat, J. H. Henderson (eds.): Psychiatric case registers in public health. Elsevier, Amsterdam 1986
15. Edwards, J. G.: The untoward effects of antipsychotic drugs -pathogenesis and management. In: Bradley, P. B., S. R. Hirsch (eds.): The psychopharmacology and treatment of schizophrenia. Oxford University Press, Oxford 1986
16. Fehlow, P., A. Tennstedt: Beitrag zur Lebenserwartung und zu den Todesursachen neuropsychiatrischer Patienten. Nervenheilkunde 13 (1994) 300-303
17. Fritze, J., B. Schneider, M. Lanczik: Vaskuläre Risikofaktoren bei affektiven Psychosen. Krankenhauspsychiatrie 4 (1993) 14-18
18. Fulop, G., R. A. Phillips, A. K. Shapiro et al.: ECG changes during haloperidol and pimozide treatment of Tourette's disorder. Am. J. Psychiatry 144 (1987) 673-675
19. Gruzelier, J. H., P. H. Venables: Evidence of high and low levels of physiological arousal in schizophrenics. Psychophysiology 12 (1975) 66-73
20. Häfner, H., H. Bickel: Physical morbidity and mortality in psychiatric patients. In: Öhman, R., H. L. Freeman, A. Franck, A. F. Holmkvist, S. Nielzen (eds.): Interaction between mental and physical illness. Needed areas of research. Springer, Berlin, Heidelberg, New York, London, Paris, Tokyo 1989
21. Haferkamp, O.: Em. Ordinarius f. allg. Pathologie d. Universität Ulm, persönliche Mitteilung (1993)
22. Herrman, H. E., J. A. Baldwin, D. Christie: A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychol. Med. 13 (1983) 581-593
23. Hewer, W., W. Rössler, E. Jung, B. Fätkenheuer: Somatische Erkrankungen bei stationär behandelten psychiatrischen Patienten. Psychiat. Prax. 18 (1991) 133-138
24. Hewer, W., W. Rössler, E. Jung: Zur Mortalität von stationär behandelten psychiatrischen Patienten im höheren Lebensalter. Klin. Wochenschr. 66, Suppl. 13 (1988) 67
25. Honig, A., P. Pop, E. de Kemp, H. Philipsen, M. A. J. Romme: Physical illness in chronic psychiatric patients from a community psychiatric unit revisited. Br. J. Psychiatry 161 (1992) 80-83
26. Hussar, A. E.: Leading causes of death in institutionalized chronic schizophrenic patients. A study of 1275 autopsy protocols. J. Nerv. Ment. Dis. 142 (1966) 45
27. Hussar, A. E., D. G. Bragg: The effect of chlorpromazine on the swallowing function in chronic schizophrenic patients. Am. J. Psychiatry 126 (1969) 570-573
28. Kirch, D. G.: Where there's smoke ... nicotine and psychiatric disorders. Biological Psychiatry 30 (1991) 107-108
29. Koranyi, E. K. (ed.): Physical illness in the psychiatric patient. Charles C. Thomas Publisher, Springfield/Illinois 1987
30. Koranyi, E. K.: Morbidity rates of undiagnosed physical illness in a psychiatric clinic. Arch. Gen. Psychiatry 36 (1979) 414-419
31. Kriwisky, M., G. Y. Perry, D. Tarchitsky et al.: Halopendol-induced Torsades de pointes. Chest 98 (1990) 482-484
32. Masterson, G., C. J. Main, A. F. Lever, R. S. Lever: Low blood pressure in psychiatric inpatients. Br. Heart J. 45 (1981) 442-446
33. McCarrick, A. K., R. W. Manderscheid, D. E. Bertolucci, H. Goldman, R. C. Tessler: Chronic medical problems in the chronic mentally ill. Hosp. Comm. Psych. 37 (1986) 289-291
34. Mehtonen, O. P., K. Aranko, L. Malkonen, H. Vapaatalo: A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr. Scand. 84 (1991) 58-64
35. Middeke, M., M. von Zedtwitz-Arnim, R. Henkel, M. A. Schreiber, U. Keil, B. Krahl, H. Holzgreve, N. Zöllner: Epidemiologie der Hypertonie. Münch. med. Wschr. 128 (1986) 840-843
36. Rassidakis, N. C.: Illnesses of the psychosomatic continuum and coronary heart disease. Int. Ment. Health Res. Newsletter 17 (1975) 6
37. Saugstad, L. F., Ö. Ödegard: Mortality in psychiatric hospitals in Norway 1950-1974. Acta Psychiatr. Scand. 59 (1979) 431-447
38. Schwalb, H., W. Schimana, H. Brüninghaus, F. Eckmann, J. Mascher, W. Selfling, I. Veh-Schindelmayr: Mortalität hospi-talisierter psychiatrischer Patienten - Ergebnisse einer 10-Jahres-Studie. Fortschr. Neurol. Psychiat. 55 (1987) 83-90
39. Sims, A.: Mortality in psychiatric patients. In: Koranyi, E. K. (ed.): Physical illness in the psychiatric patient Charles C. Thomas Publisher, Springfield/Ilinois 1987
40. Thorogood, M., P. Cowen, J. Mann, M. Murphy, M. Vessey: Fatal myocardial infarction and use of psychotropic drugs in young women. The Lancet 340 (1992) 1067-1068.
41. Editorial: Psychotropic drugs and myocardial infarction: cause for or caused by panic? The Lancet 340 (1992) 1069-1070
42. Trabert, W.: Letale Schlucksynkopen in der Psychiatrie. Psycho 16 (1990) 23-27
43. Tsuang, M. T., K. Perkins, J. C. Simpson: Physical diseases in schizophrenia and affective disorder. J. Gin. Psychiatry 44 (1983) 42-46
44. Tueth, M. J.: Emergencies caused by side effects of psychiatric medications. Am. J. Emerg. Med. 12 (1994) 212-216
45. Ungvari, G.: Neuroleptische Behandlung und unerwarteter Tod. Fortschr. Neurol. Psychiat. 50 (1982) 267-273
46. Volz, H. P., A. Mackert: Kardiovaskuläre Regulationsstörungen bei Schizophrenen - mehr als ein Epiphänomen? Nervenarzt 62 (1991) 298-302
47. Walter-Ryan, W. G., R. D. Alarcon, D. T. Meadows, R. Westbrook: Toward a profile of medically ill psychiatric patients. South. Med. J. 80 (1987) 822-826
48. Zahn, T. P., W. T. Carpenter, T. H. Glashan: Autonomic nervous responsitivity in acute schizophrenia. Arch. Gen. Psychiatry 38 (1981) 251-266
49. Zahn, T. P.: Psychophysiological approaches to psychopathology. In: Coles, G. H., S. W. Douchin, S. W. Forges (eds.): Psychophysiology - systems, processes and applications. Guilford, New York 1986